How Dr. Yasir Qazi embraced cell-free DNA surveillance, an unaffected approach due to the recent CMS update
Fill form to unlock content
Loading, please wait
Error - something went wrong!
Please fill out form to access this item.
Thank you!
Hear from our ProActive Study Investigator In this episode of our Inside the ProActive Study Podcast, Dr. Yasir Qazi talks to us about:
• His dd-cfDNA “surveillance journey” and protocol development.
• Identifying “high risk patients” and “high risk situations” for dd-cfDNA surveillance.
• Maintaining access and utilization of dd-cfDNA for patient care, despite the latest CMS Guidance.